On the other hand, lowering of PON-1 activity was associated with an increase in LVIDdn and LVIDsn measurements, as well as MV E/A ratio, which are markers of advanced cardiac disease and decompensated heart failure [43,44], regardless of group. Here, PON1 is linked to heart disorder.